Gene mutation, clinical characteristics and pathology in resectable lung adenocarcinoma
Abstract Objective With the wide use of CT scan in clinical practice, more lung cancer was diagnosed in resectable stage. Pathological examination and genetic testing have become a routine procedure for lung adenocarcinoma following radical resection. This study analyzed special pathological compone...
Saved in:
Main Authors: | Ji’an Zou, Wei Han, Yan Hu, Chao Zeng, Jina Li, Weixuan Lei, Jieming Cao, Quanming Fei, Mengqi Shao, Junqi Yi, Zeyu Cheng, Li Wang, Fang Wu, Wenliang Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | World Journal of Surgical Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12957-025-03680-x |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gene mutation in diabetic patients with lung adenocarcinoma: a real-world retrospective cohort study
by: Lei Yang, et al.
Published: (2025-01-01) -
Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma
by: Ruilan Ma, et al.
Published: (2025-02-01) -
STK11 mutation affects tumor proliferation by impacting CD4+ T cell activity in lung adenocarcinoma
by: Jiemeng Ge, et al.
Published: (2024-10-01) -
EGFR-Mutated Lung Adenocarcinoma With Li–Fraumeni Syndrome: The Imperative for Germline Testing in Patients With a Family History, a Case Report
by: Hiroyuki Fujii, MD, et al.
Published: (2025-02-01) -
Tepotinib for the Treatment of Lung Adenocarcinoma Harboring MET Y1003N Point Mutation: A Case Report
by: Yukihiro Umeda, et al.
Published: (2025-01-01)